The surprising number of patient families with FDXR mutations that have been discovered in such a short period of time raises the possibility that the FDXR/FDX1/FDX2 pathway may lie behind many cases of optic atrophy and ataxia with no previously identified cause. This evidence concerns the gene FDX2 and optic atrophy.